Andrej Roczkowsky

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Peroxisomes as emerging clinical targets in neuroinflammatory diseases.

Peroxisomes as emerging clinical targets in neuroinflammatory diseases.

Journal: Frontiers in molecular neuroscience
Published: June 06, 2025

Matrix metalloproteinase inhibition protects against junctophilin-2 proteolysis during doxorubicin-induced cardiotoxicity.

Matrix metalloproteinase inhibition protects against junctophilin-2 proteolysis during doxorubicin-induced cardiotoxicity.

Journal: British journal of pharmacology
Published: November 25, 2024

N-Terminomic Identification of Intracellular MMP-2 Substrates in Cardiac Tissue.

N-Terminomic Identification of Intracellular MMP-2 Substrates in Cardiac Tissue.

Journal: Journal of proteome research
Published: April 22, 2024

Data-Independent Acquisition Proteomics and N-Terminomics Methods Reveal Alterations in Mitochondrial Function and Metabolism in Ischemic-Reperfused Hearts.

Data-Independent Acquisition Proteomics and N-Terminomics Methods Reveal Alterations in Mitochondrial Function and Metabolism in Ischemic-Reperfused Hearts.

Journal: Journal of proteome research
Published: January 24, 2024

COVID-19 Induces Neuroinflammation and Suppresses Peroxisomes in the Brain.

COVID-19 Induces Neuroinflammation and Suppresses Peroxisomes in the Brain.

Journal: Annals of neurology
Published: December 20, 2022

Peroxisome Injury in Multiple Sclerosis: Protective Effects of 4-Phenylbutyrate in CNS-Associated Macrophages.

Peroxisome Injury in Multiple Sclerosis: Protective Effects of 4-Phenylbutyrate in CNS-Associated Macrophages.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: February 12, 2022

Infection of Glia by Human Pegivirus Suppresses Peroxisomal and Antiviral Signaling Pathways.

Infection of Glia by Human Pegivirus Suppresses Peroxisomal and Antiviral Signaling Pathways.

Journal: Journal of virology
Published: September 15, 2021

MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling.

MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling.

Journal: Cardiovascular research
Published: August 23, 2019

Junctophilin-2 is a target of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury.

Junctophilin-2 is a target of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury.

Journal: Basic research in cardiology
Published: April 18, 2019

Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia-reperfusion injury.

Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia-reperfusion injury.

Journal: Cardiovascular research
Published: December 13, 2018

Doxorubicin induces de novo expression of N-terminal-truncated matrix metalloproteinase-2 in cardiac myocytes.

Doxorubicin induces de novo expression of N-terminal-truncated matrix metalloproteinase-2 in cardiac myocytes.

Journal: Canadian journal of physiology and pharmacology
Published: October 12, 2018

Structure and proteolytic susceptibility of the inhibitory C-terminal tail of cardiac troponin I.

Structure and proteolytic susceptibility of the inhibitory C-terminal tail of cardiac troponin I.

Journal: Biochimica et biophysica acta. General subjects
Published: September 14, 2018
Showing 1-12 of 12

Last Updated: 09/26/2026